Results 71 to 80 of about 1,175 (172)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids

Drug Design, Development and Therapy, 2014
Nicoletta Biglia,1 Silvestro Carinelli,2 Antonio Maiorana,3 Marta D'Alonzo,1 Giuseppe Lo Monte,4 Roberto Marci4 1Department of Obstetrics and Gynaecology, Mauriziano "Umberto I" Hospital, University of Turin, Turin, 2Department of Pathology,
Biglia N, Carinelli S, Maiorana A, D'Alonzo M, Lo Monte G, Marci R   +5 more
doaj  

Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women

ClinicoEconomics and Outcomes Research, 2017
Marco Chiumente,1 Mauro De Rosa,2 Andrea Messori,2 Enrica Maria Proli3 1Scientific Direction, SIFaCT – Italian Society for Clinical Pharmacy and Therapeutics, Milan, 2Board of directors, SIFaCT - Italian Society for Clinical Pharmacy and ...
Chiumente M, De Rosa M, Messori A, Proli EM   +3 more
doaj  

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. [PDF]

Hum Mol Genet, 2023
Kolterud Å, Välimäki N, Kuisma H, Patomo J, Ilves ST, Mäkinen N, Kaukomaa J, Palin K, Kaasinen E, Karhu A, Pasanen A, Bützow R, Heikinheimo O, Kopp Kallner H, Aaltonen LA.   +14 more
europepmc   +1 more source

Emergency contraception: current options, challenges, and future directions

Open Access Journal of Contraception, 2011
Serena Dovey, Joseph Sanfilippo Magee Women’s Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Abstract: The term emergency contraception (EC) refers to utilizing a medication or placing a copper intrauterine device within
Dovey S, Sanfilippo J
doaj  

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids. [PDF]

Facts Views Vis Obgyn, 2023
Lambrecht I, Van den Bosch T.
europepmc   +1 more source

Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects

Integrated Pharmacy Research and Practice, 2017
Sally Rafie,1 Rebecca H Stone,2 Tracey A Wilkinson,3 Laura M Borgelt,4,5 Shareen Y El-Ibiary,6 Denise Ragland7 1Department of Pharmacy, UC San Diego Health, San Diego, CA, 2Department of Clinical and Administrative Pharmacy, University of Georgia ...
Rafie S, Stone RH, Wilkinson TA, Borgelt LM, El-Ibiary SY, Ragland D   +5 more
doaj  

Decreased growth differentiation factor 9, bone morphogenetic protein 15, and forkhead box O3a expressions in the ovary via ulipristal acetate. [PDF]

Rev Assoc Med Bras (1992), 2023
Fındık DG, Kaplanoğlu GT, Arık GN, Alemari NBA.   +3 more
europepmc   +1 more source

Different approach to conserving therapy of uterine fibroids in women of reproductive age [PDF]

Гинекология, 2015
The aim of the study was to evaluate the effectiveness of integrated treatment of uterine fibroids in women of reproductive age; 103 women of reproductive age of minimally invasive myomectomy performed accesses.
A N Plekhanov, N A Tatarova, Yu S Shishkina   +2 more
doaj  

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. [PDF]

Hum Reprod, 2022
Middelkoop MA, de Lange ME, Clark TJ, Mol BWJ, Bet PM, Huirne JAF, Hehenkamp WJK.   +6 more
europepmc   +1 more source

The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. [PDF]

Breast Cancer Res Treat, 2022
Westhoff CL, Guo H, Wang Z, Hibshoosh H, Polaneczky M, Pike MC, Ha R.   +6 more
europepmc   +1 more source